Loading
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.
NASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$10.27
−$0.2802 · -2.66%
Previous close
$10.27
−$0.2802 · -2.66%
Regular session · ET · Market data may be delayed.
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.
Day range
Current $10.27
52-week range
Current $10.27
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
90
Deep Value
Sentiment
64
Bullish
Risk
57
Elevated Risk
Momentum
35
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.
Day range
Current $10.27
52-week range
Current $10.27
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 503.42K USD | 2.13M USD | 34.59M USD | −353.36K USD | −2.62M USD |
| Cost of goods sold | 314.68K USD | — | 177.08K USD | 1.09M USD | 1M USD |
| Gross profit | 188.74K USD | 2.13M USD | 34.41M USD | −1.44M USD | −3.62M USD |
| Research and development | — | — | — | −14.65 USD | — |
| Selling, general, and administrative | — | 294.19K USD | 307.36K USD | 1.09M USD | 991.31K USD |
| Operating expenses | −9M USD | 1.59M USD | 939.06K USD | 1.09M USD | 1.07M USD |
| Interest income | 26.69K USD | — | — | — | — |
| Interest expense | 15.96K USD | 85.09K USD | 49.1K USD | 72.45K USD | 19.61K USD |
| Depreciation and amortization | — | 1.44M USD | 506.82K USD | 859.73K USD | 745.58K USD |
| Operating income | 9.19M USD | 621.42K USD | 329.74K USD | 5.25M USD | 4.75M USD |
| Net income | 9.17M USD | 536.33K USD | 280.64K USD | 5.18M USD | 4.75M USD |
Company facts updated Sep 7, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$23.00
123.95% upsideLimited analyst sample: 3 ratings. Interpret the distribution with caution.
Cash distributions grouped by calendar year; partial years are marked.
$0.20
2012 complete year-86.7% since 2008
$1.50
2,008
$1.35
2,009
$1.00
2,010
$0.35
2,011
$0.20
2,012
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jan 5, 2018 | $0.03Monthly | Jan 8, 2018 | Jan 12, 2018 |
Dividend | Dec 20, 2017 | $0.03Annual | — | — |
Dividend | Dec 20, 2016 | $0.03Annual | Dec 22, 2016 | Dec 29, 2016 |
Dividend | Dec 18, 2015 | $0.04Annual | Dec 22, 2015 | Dec 29, 2015 |
Dividend | Dec 4, 2014 | $0.03Annual | Dec 8, 2014 | Dec 26, 2014 |
Dividend | Dec 5, 2013 | $0.05Annual | Dec 9, 2013 | Dec 27, 2013 |
Ex-dividend Jan 5, 2018
$0.03
Monthly
Record Jan 8, 2018 · Payment Jan 12, 2018
Ex-dividend Dec 20, 2017
$0.03
Annual
Ex-dividend Dec 20, 2016
$0.03
Annual
Record Dec 22, 2016 · Payment Dec 29, 2016
Ex-dividend Dec 18, 2015
$0.04
Annual
Record Dec 22, 2015 · Payment Dec 29, 2015
Ex-dividend Dec 4, 2014
$0.03
Annual
Record Dec 8, 2014 · Payment Dec 26, 2014
Ex-dividend Dec 5, 2013
$0.05
Annual
Record Dec 9, 2013 · Payment Dec 27, 2013
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
